文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

宫颈癌IMRT骨髓保护的最佳剂量限制策略

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer.
PubMed 文献 · Radiat Oncol · 2019-08-05

BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT).…

要点

  • 以髋骨和腰骶椎为骨髓OAR的IMRT计划骨髓保护最优。
  • 该计划不增加小肠、膀胱、直肠和股骨头剂量。
  • 推荐在宫颈癌术后IMRT中增加髋骨和腰骶椎为骨髓OAR。

核心结论

  • 以髋骨和腰骶椎作为剂量体积限制可最佳保护骨髓且不牺牲周围正常结构剂量。
  • 推荐在宫颈癌术后IMRT计划中将髋骨和腰骶椎添加为骨髓OAR。

研究设计与样本

  • 每例生成四种IMRT计划:无骨髓约束的IMRT(N)、以骨髓为OAR的IMRT(BM)、以髋骨为OAR的IMRT(OC)、以髋骨和腰骶椎为OAR的IMRT(OC+LS)。
  • 采用方差分析(ANOVA)比较靶区和OAR的剂量体积参数。

主要发现

  • 三种BMS-IMRT计划中小肠、膀胱、直肠和股骨头的剂量均未增加。
  • IMRT(BM)计划中骨髓、髋骨和腰骶椎的平均剂量降低约5Gy(p < 0.05),V20、V30、V40平均降低7.1-24.2%。
  • IMRT(OC+LS)计划中腰骶椎V40降低幅度最大(约31.2%,p < 0.05)。
  • 与IMRT(BM)相比,IMRT(OC)降低髋骨剂量体积但增加腰骶椎剂量,IMRT(OC+LS)降低髋骨和腰骶椎所有剂量水平体积。
  • IMRT(OC+LS)计划中髋骨和腰骶椎的V20分别降低11.5%和11.2%。

关键数值与推荐

  • IMRT(BM)计划中骨髓、髋骨和腰骶椎平均剂量降低约5Gy(p < 0.05)。
  • IMRT(BM)计划中V20、V30、V40平均降低7.1-24.2%。
  • IMRT(OC+LS)计划中腰骶椎V40降低约31.2%(p < 0.05)。
  • IMRT(OC+LS)计划中髋骨和腰骶椎V20分别降低11.5%和11.2%。

临床怎么用

  • 宫颈癌术后IMRT计划设计时,可将髋骨和腰骶椎设为骨髓OAR并施加剂量体积约束。
  • 该策略在不增加小肠、膀胱、直肠和股骨头剂量的前提下降低骨髓受量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). RESULTS: Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1-24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V20 of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. CONCLUSION: By introducing the os coxae and lumbosacral spine as the dose-volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bao Z, Wang D, Chen S, et al. Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer. Radiat Oncol. 2019. PMID: 31378200. doi:10.1186/s13014-019-1324-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。